Lahore: S.G. Power Limited has unveiled a substantial capital expansion plan through the issuance of right shares, aimed at bolstering its financial base and supporting strategic growth within the healthcare and pharmaceutical sectors. This development was confirmed after a board meeting held on May 18, 2026, in Lahore, Pakistan.
In line with the company’s long-term growth objectives, the Board of Directors approved the issuance of 53.5 million right shares at a par value of PKR 10 per share, culminating in an aggregate value of PKR 534.996 million. This move intends to enhance the company’s capital base, improve financial flexibility, and support planned expansion initiatives. The proposed right shares will be offered in a proportion of approximately three right shares for every one ordinary share held, translating to a 300% increase in the company’s existing paid-up capital.
According to information available from the Pakistan Stock Exchange (PSX), the board has resolved to determine and communicate the book closure dates and other relevant details separately, ensuring compliance with all applicable corporate, legal, and regulatory requirements. The capital raised will be strategically deployed to strengthen S.G. Power Limited’s operations in the healthcare sector, providing necessary resources for future growth opportunities.
The primary aim of the right issue is to invest in healthcare and related businesses, thereby diversifying and strengthening the company’s revenue base. The enhanced capital is expected to support operational expansion, improve profitability, and deliver higher returns to shareholders. Furthermore, this capital infusion will directly strengthen the company’s equity base and financial flexibility, enabling it to pursue larger business opportunities while adhering to prudent financial and risk management practices.
Despite the anticipated benefits, the company acknowledges the normal risks associated with business and the healthcare sector, including market, regulatory, and operational risks. However, significant shareholders and directors have committed to subscribing to their respective entitlements, ensuring the right issue’s success and providing confidence to the market.